Restriction landmark genomic scanning applied to a broad variety of cancer types can disclose tumour-specific and tumour-type–specific global methylation profiles. This and other genome-scanning approaches allows the rapid analysis of methylation profiles of thousands of genes in parallel—and promises to identify new genes critical to carcinogenesis and other biological processes.